NeuroSense Therapeutics Ltd. NRSN stock price is finally showing some life as it reverses trend. NRSN is up 55% in the last 5 days.
The volume is up over 140%, that is a great sign.
I will be evaluating many factors to determine just how HOT, the stock NSRN is.
The official HOT level for NRSN is, a 🔥🔥🔥 3 out of 5.
Continue reading to see why I think it is just a 3 out of 5. There is some shocking takeaways from this article that you must read if you are interested in SMCE.
If you are interested in finding out more about me, famed stock picker, Alexander Goldman or if you’re interested in my HOT grading system, sign up today, it’s FREE!
👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇 In fact, I will send you personally a 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter.
Before I go over this exciting trending stock, I wanted to introduce myself. Hello 🙋♂️ My name is Alexander Goldman. I have been trading, at a very high level, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT grading system for trending stocks.
I found my home at Small Cap exclusive 4 years ago. Now, I’m helping traders find breakout stocks. Not to sound egotistical but I’m very good at finding small cap stocks that are winners.
What do I mean by big winners?
Stocks that move more than 100% in a month! NRSN Stock Price could?
Does that always happen, NO! But, I’m very consistent! Take a look at this article I wrote below, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!
The article is HERE and I shine a spotlight on these breakout stocks and also those losers!
Now, let’s go over some of the basic information on this stock before we get in the technical analysis and how I came up with HOT grade.
NeuroSense Therapeutics Ltd. Company Information
Company Name: NeuroSense Therapeutics Ltd.
Breakout Stock NeuroSense Therapeutics Ltd. Company Summary:
Neurosense Therapeutics Ltd. operates as a clinical stage drug development company. It offers ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases. The company was founded by Alon Ben-Noon in February 2017 and is headquartered in Herzeliya, Israel.
NRSN stock price is due to News?
June 28, 2022 – FinancialNewsMedia.com News Commentary – Pancreatic cancer therapeutics and diagnostics involve medical procedures used to diagnose pancreatic cancer and subsequent treatment. Factors such as the increasing prevalence and incidence of pancreatic cancer and advancements in molecular biology, development of drugs, and diagnostic technology play a major part in market growth. With the increase in R&D initiatives, favorable reimbursement scenarios, and the launch of novel products, the market is expected to grow significantly during the forecast period. A report from Mordor Intelligence projected that the global pancreatic cancer therapeutics and diagnostics market, which was estimated to be USD 3,689.61 million in 2021 is expected to reach USD 5,656.58 million by 2027, registering a CAGR of 7.43% from 2022 to 2027.
March 21, 2022 /PRNewswire via COMTEX/ — CAMBRIDGE, Mass., March 21, 2022 /PRNewswire/ — NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.
PrimeC is a novel extended-release oral formulation composed of a unique fixed-dose combination of two FDA-approved drugs: ciprofloxacin and celecoxib. PrimeC is designed to synergistically target several key mechanisms of amyotrophic lateral sclerosis (ALS) that contribute to motor neuron degeneration, inflammation, iron accumulation and impaired RNA regulation to potentially inhibit the progression of ALS.
Trending Stock NRSN 5 Day Chart
NRSN Stock Price HOT Stock Grade:
The official heat level for NSRN is, a 🔥🔥 3 out of 5 . Continue reading to see why I think it is just a 3 out of 5. Here are my takeaways on NSRN and why it is just a 2 out of 5.
The volume, is the demand for a stock and this one is great! Up 140% over normal trading.
The news, is solid and the market has responded.
The chart, I like it, the chart is consolidated and appears to be ready to make another move.
The fundamentals, the vertical is a very profitable one!
Marketing efforts, I have not found a significant awareness campaign running. Furthermore, with news like this, there should be an effort to disseminate the important news to investors.
To receive my 🔥🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.
👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥🔥 HOT stocks and trending stocks!👇